SCHEMBL21569738

SCHEMBL21569738

NC(=O)CCOCCOCCOCCN1C(=O)C=CC1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 6/20 0.69
PTGS1 P23219 7/20 0.42
PTGS2 P35354 7/20 0.42
FAAH O00519 3/20 0.41
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSP90AA1 P07900 2/20 0.39
TLR9 Q9NR96 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR35 Q9HC97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31171033 1.00 MGLL (0.69) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL24164310 1.00 MGLL (0.69) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL22708691 0.98 MGLL (0.66) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL4619174 0.86 MGLL (0.69) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL5208692 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL27420754 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL22311909 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL15215618 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL17732171 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL13733359 0.84 MGLL (0.71) MGLLPTGS1PTGS2FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023280227-A2 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PROFOUNDBIO US CO. (US) 2023-01-12 WO disclosed
US-20190345254-A1 CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME ZYMEWORKS INC (CA) 2019-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190345254-A1 CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME CCNB1, PLK1, BOD1L1 MGLL 2504/4885PTGS1 4562/4885PTGS2 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.